Protalix BioTherapeutics (PLX) Capital Expenditures (2010 - 2026)
Protalix BioTherapeutics (PLX) posted Capital Expenditures of $593,000 for Q2 2026, up 37.6% from $431,000 a year earlier but down 22.1% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Capital Expenditures (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Protalix BioTherapeutics was $2.26 million, up 80.5% year-over-year; for FY2025, it came in at $1.64 million, up 27.8% from FY2024.
- Annual Capital Expenditures has increased for three consecutive years, with a five-year compound annual growth rate of 20.1% (FY2020 to FY2025).
- In prior years, Protalix BioTherapeutics' Capital Expenditures was $1.28 million in FY2024 (+11.6%), $1.15 million in FY2023 (+83.0%), $628,000 in FY2022 (-57.0%) and $1.46 million in FY2021 (+122.7%).
- Quarterly Capital Expenditures has run from a low of $58,000 in Q3 2022 to a high of $761,000 in Q1 2026 over five years.
- On a year-over-year basis, Capital Expenditures increased in five of the last eight quarters, with growth averaging 93.1%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2023, with growth of 670.7%; the weakest was Q3 2022, with a decline of 83.1%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $761,000 (Q1 2026), $403,000 (Q4 2025) and $498,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn | 593,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 593,000.00 |
| Mar 31, 2026 | 761,000.00 |
| Dec 31, 2025 | 403,000.00 |
| Sep 30, 2025 | 498,000.00 |
| Jun 30, 2025 | 431,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Dec 31, 2024 | 425,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 172,000.00 |
| Mar 31, 2024 | 598,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Sep 30, 2023 | 447,000.00 |
| Jun 30, 2023 | 204,000.00 |
| Mar 31, 2023 | 248,000.00 |
| Dec 31, 2022 | 213,000.00 |
| Sep 30, 2022 | 58,000.00 |
| Jun 30, 2022 | 128,000.00 |
| Mar 31, 2022 | 229,000.00 |
| Dec 31, 2021 | 448,000.00 |
| Sep 30, 2021 | 344,000.00 |
API Access
Protalix BioTherapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();